UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Development and validation of an International Prognostic Score of thrombosis in World Health Organization–essential thrombocythemia (IPSET-thrombosis)

Blood, 2012-12, Vol.120 (26), p.5128-5133

2012

Volltextzugriff (PDF)

Cardiovascular Events and Intensity of Treatment in Polycythemia Vera

The New England journal of medicine, 2013-01, Vol.368 (1), p.22-33

2013

Volltextzugriff (PDF)

Masked polycythemia Vera (mPV): Results of an international study

American journal of hematology, 2014-01, Vol.89 (1), p.52-54

2014

Volltextzugriff (PDF)

Initial bone marrow reticulin fibrosis in polycythemia vera exerts an impact on clinical outcome

Blood, 2012-03, Vol.119 (10), p.2239-2241

2012

Volltextzugriff (PDF)

Masked polycythemia vera diagnosed according to WHO and BCSH classification

American journal of hematology, 2014-02, Vol.89 (2), p.199-202

2014

Volltextzugriff (PDF)

The Dysprothrombinemias due to Arg596 Mutations: A Conundrum With No Bleeding Tendency and Venous Thrombosis due to Antithrombin Resistance

Clinical and applied thrombosis/hemostasis, 2019-01, Vol.25, p.1076029619841701-1076029619841701

2019

Volltextzugriff (PDF)

Novel point mutation in a leucine-rich repeat of the GPIbα chain of the platelet von Willebrand factor receptor, GPIb/IX/V, resulting in an inherited dominant form of Bernard-Soulier syndrome affecting two unrelated families : the N41H variant

Haematologica (Roma), 2008-11, Vol.93 (11), p.1743-1747

2008

Volltextzugriff (PDF)

Acute myeloid leukemia: from NGS, through scRNA-seq, to CAR-T. dissect cancer heterogeneity and tailor the treatment

Journal of experimental & clinical cancer research, 2023-10, Vol.42 (1), p.1-259, Article 259

2023

Volltextzugriff (PDF)

Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients

Blood, 2011-06, Vol.117 (22), p.5857-5859

2011

Volltextzugriff (PDF)

Hematologic Neoplasms Associated with Down Syndrome: Cellular and Molecular Heterogeneity of the Diseases

International journal of molecular sciences, 2023-10, Vol.24 (20), p.15325

2023

Volltextzugriff (PDF)

Essential Thrombocythemia in Children and Adolescents

Cancers, 2021-12, Vol.13 (23), p.6147

2021

Volltextzugriff (PDF)

Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study

Journal of clinical oncology, 2011-08, Vol.29 (23), p.3179-3184

2011

Volltextzugriff (PDF)

Clinical effect of CALR allele burden in patients with essential thrombocythemia

Annals of hematology, 2022-06, Vol.101 (6), p.1345-1346

2022

Volltextzugriff (PDF)

Vitamin K-Dependent Coagulation Factors That May be Responsible for Both Bleeding and Thrombosis (FII, FVII, and FIX)

Clinical and Applied Thrombosis/Hemostasis, 2018-12, Vol.24 (9_suppl), p.42S-47S

2018

Volltextzugriff (PDF)

The effect of arterial hypertension on thrombosis in low‐risk polycythemia vera

American journal of hematology, 2017-01, Vol.92 (1), p.E5-E6

2017

Volltextzugriff (PDF)

Genetic Basis of Congenital Erythrocytosis: Mutation Update and Online Databases

Human mutation, 2014-01, Vol.35 (1), p.15-26

2014

Volltextzugriff (PDF)

P1014: GERMINAL JAK2 MOLECULAR ALTERATIONS IN PATIENTS WITH IDIOPATHIC ERYTHROCYTOSIS

HemaSphere, 2023-08, Vol.7 (S3), p.e231473f-n/a

2023

Volltextzugriff (PDF)

Characterization of genetic variants in the EGLN1/PHD2 gene identified in a European collection of patients with erythrocytosis

Haematologica (Roma), 2023-11, Vol.108 (11), p.3068-3085

2023

Volltextzugriff (PDF)

Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPN

American journal of hematology, 2012-05, Vol.87 (5), p.552-554

2012

Volltextzugriff (PDF)

Disease characteristics and clinical outcome in young adults with essential thrombocythemia versus early/prefibrotic primary myelofibrosis

Blood, 2012-07, Vol.120 (3), p.569-571

2012

Volltextzugriff (PDF)

Extremely Old Patients Hospitalized in Internal Medicine: What about Their Anemia?

Mediterranean journal of hematology and infectious diseases, 2021-05, Vol.13 (1), p.e2021038-e2021038

2021

Volltextzugriff (PDF)

Survival expectation after thrombosis and overt-myelofibrosis in essential thrombocythemia and prefibrotic myelofibrosis: a multistate model approach

Blood cancer journal (New York), 2023-07, Vol.13 (1), p.115-115, Article 115

2023

Volltextzugriff (PDF)

The Story of Serum Prothrombin Conversion Accelerator, Proconvertin, Stable Factor, Cothromboplastin, Prothrombin Accelerator or Autoprothrombin I, and Their Subsequent Merging into Factor VII

Seminars in thrombosis and hemostasis, 2015-06, Vol.41 (4), p.366-373

2015

Volltextzugriff (PDF)

1 – 25 von 152

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(141)
Mit Volltextzugriff
(127)

Publikationsform

Artikel
(151)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(98)
Science & Technology
(98)
Humans
(89)
Hematology
(78)
Female
(68)
Male
(62)
Adult
(57)
Middle Aged
(48)
Aged
(38)
Biological And Medical Sciences
(32)
Medical Sciences
(32)
Hematologic And Hematopoietic Diseases
(28)
Adolescent
(23)
Risk Factors
(20)
Aged, 80 And Over
(19)
Thrombosis
(19)
Janus Kinase 2 - Genetics
(17)
Retrospective Studies
(17)
Child
(16)
Essential Thrombocythemia
(15)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Development and validation of an International Prognostic Score of thrombosis in World Health Organization–essential thrombocythemia (IPSET-thrombosis)

Cardiovascular Events and Intensity of Treatment in Polycythemia Vera

A prognostic model to predict survival in 867 World Health Organization–defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and Treatment

Masked polycythemia Vera (mPV): Results of an international study

Initial bone marrow reticulin fibrosis in polycythemia vera exerts an impact on clinical outcome

Masked polycythemia vera diagnosed according to WHO and BCSH classification

The Dysprothrombinemias due to Arg596 Mutations: A Conundrum With No Bleeding Tendency and Venous Thrombosis due to Antithrombin Resistance

Novel point mutation in a leucine-rich repeat of the GPIbα chain of the platelet von Willebrand factor receptor, GPIb/IX/V, resulting in an inherited dominant form of Bernard-Soulier syndrome affecting two unrelated families : the N41H variant

Acute myeloid leukemia: from NGS, through scRNA-seq, to CAR-T. dissect cancer heterogeneity and tailor the treatment

A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia

Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients

Hematologic Neoplasms Associated with Down Syndrome: Cellular and Molecular Heterogeneity of the Diseases

Essential Thrombocythemia in Children and Adolescents

Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study

Clinical effect of CALR allele burden in patients with essential thrombocythemia

Vitamin K-Dependent Coagulation Factors That May be Responsible for Both Bleeding and Thrombosis (FII, FVII, and FIX)

The effect of arterial hypertension on thrombosis in low‐risk polycythemia vera

Genetic Basis of Congenital Erythrocytosis: Mutation Update and Online Databases

P1014: GERMINAL JAK2 MOLECULAR ALTERATIONS IN PATIENTS WITH IDIOPATHIC ERYTHROCYTOSIS

Characterization of genetic variants in the EGLN1/PHD2 gene identified in a European collection of patients with erythrocytosis

Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPN

Disease characteristics and clinical outcome in young adults with essential thrombocythemia versus early/prefibrotic primary myelofibrosis

Extremely Old Patients Hospitalized in Internal Medicine: What about Their Anemia?

Survival expectation after thrombosis and overt-myelofibrosis in essential thrombocythemia and prefibrotic myelofibrosis: a multistate model approach

The Story of Serum Prothrombin Conversion Accelerator, Proconvertin, Stable Factor, Cothromboplastin, Prothrombin Accelerator or Autoprothrombin I, and Their Subsequent Merging into Factor VII

Suchergebnisse filtern